GTBP · GT Biopharma, Inc.
$0.32
-0.01 (-2.61%)
At close · Aug 5
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date that the financial statements are issued. In addition, the Company’s independent registered public accounting firm, in its report on the Company’s December 31, 2025, financial statements, raised substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed May 15, 2026
Market Cap
$11.45M
Shares
36.06M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$0
FY2020
Net Income
-$28.35M
-115.4%
FY2025
Gross Margin
100%
+93.4pp
FY2015
Operating Margin
-33062.96%
-29135.1pp
FY2015
Diluted EPS
-$6.68
+3.7%
FY2025
Operating Cash Flow
-$12.91M
-0.1%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $0 | — | — | — | — | — | $0 | $0 | — | $0 | $0 | $27K | $61K | $368K | $342K | $26K | $11K | |
| — | — | — | — | — | — | — | — | — | $0 | $0 | $0 | $57K | $226K | $94K | $48K | $65K | |
| — | — | — | — | — | — | — | — | — | $0 | $0 | $27K | $4000 | $142K | $248K | -$22K | -$54K | |
| — | — | — | — | — | — | — | — | — | — | — | 100% | 6.56% | 38.59% | 72.51% | -84.62% | -490.91% | |
| $2.79M | $3.47M | $5.8M | $6.47M | $8.81M | $9.59M | $485K | $1.67M | $9.07M | $1.07M | $975K | $1M | $0 | $0 | $0 | $17K | $179K | |
| $10.55M | $8.95M | $8.57M | $7.11M | $12.45M | $47.92M | $6.28M | $9.79M | $12.49M | $134.5M | $8.4M | $7.95M | $2.4M | $935K | $3.36M | $3.47M | $2.26M | |
| — | — | — | — | — | — | — | — | — | $0 | $0 | $0 | $22K | $2000 | $3000 | $23K | $31K | |
| — | — | — | $13.58M | $21.26M | $57.52M | — | $16.06M | $250.07M | $135.57M | $9.37M | $8.95M | $2.4M | $935K | $3.76M | $3.91M | $2.44M | |
| -$13.34M | -$12.42M | -$14.36M | -$13.58M | -$21.26M | -$57.52M | -$6.76M | $16.06M | -$250.07M | -$135.57M | -$9.37M | -$8.93M | -$2.4M | -$793K | -$3.51M | -$3.93M | -$2.5M | |
| — | — | — | — | — | — | — | — | — | — | — | -33062.96% | -3927.87% | -215.49% | -1027.49% | -15107.69% | -22700% | |
| — | $127K | — | $213K | $8000 | $718K | -$3M | -$2.13M | $9.12M | $8.6M | $6.56M | $17.04M | $5.15M | $1.2M | $1.65M | $556K | $513K | |
| -$17.07M | -$15.93M | $1.2M | $5.98M | $373K | -$498K | -$21.53M | $22.59M | -$9.12M | -$8.6M | $19.14M | -$12.53M | -$21.11M | $229K | -$1.75M | $228K | -$498K | |
| -$14.83M | — | — | — | — | — | — | -$38.65M | -$259.19M | -$144.17M | $9.77M | -$21.46M | -$23.51M | -$564K | -$5.26M | -$3.7M | -$3M | |
| $0 | — | — | — | — | — | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | |
| -$30.41M | -$28.35M | -$13.16M | -$7.6M | -$20.88M | -$58.01M | -$28.3M | -$38.65M | -$259.19M | -$144.17M | $9.77M | -$21.46M | -$23.49M | -$501K | -$5.17M | -$3.7M | -$3M | |
| — | — | — | — | — | — | — | — | — | — | — | -79485.19% | -38506.56% | -136.14% | -1511.99% | -14230.77% | -27227.27% | |
| — | — | — | — | — | — | — | — | — | $0 | $0 | $0 | -$16K | -$63K | -$90K | $0 | — | |
| -$37.04M | -$34.45M | -$13.16M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| USD/shares | — | -$6.68 | -$6.94 | -$5.64 | -$19.66 | -$61.80 | — | — | -$2,631.60 | -$4,386.00 | $61,154.10 | -$4,569.60 | — | — | — | — | — |
| USD/shares | — | -$6.68 | -$6.94 | -$5.64 | -$19.66 | — | — | — | -$2,631.60 | -$4,386.00 | $61,154.10 | -$4,569.60 | — | — | — | — | — |
| shares | — | 5.51M | 1.9M | 1.35M | 1.06M | 938.52K | 146.17K | — | 98.5098 | 32.8804 | 159.7255 | 4695.1765 | 4564.4569 | 1.11M | 728.87K | 394.31K | — |
| shares | — | 5.51M | 1.9M | 1.35M | 1.06M | 938.52K | 146.17K | 112.8K | 98.5098 | 32.8804 | 159.7255 | 4695.1765 | 4564.4569 | 1.11M | 728.87K | 394.31K | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
EV/EBIT
—
P/E (TTM)
—
Peer median 0.04×
Peer medians compare against the 199 similar-size Biotechnology companies (of 520 listed).
Key facts
CIK
109657
CUSIP
36254L308
13F (30d)
18 filings
18 filers
Visit website
Investor relations